查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1496078

呼吸系統介入的全球市場 - 全球產業分析，規模，佔有率，成長，趨勢，預測(2031年)- 各產品，各適應症，各終端用戶，各地區

Interventional Pulmonology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
出版日期: | 出版商: Fairfield Market Research | 英文 270 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

預計到 2024 年，全球呼吸介入市場規模將達到 13 億美元，並且未來有望大幅成長。該市場預計將以 5% 的複合年增長率成長，到 2031 年將達到 18.5 億美元。這一強勁增長是由慢性阻塞性肺病（COPD）患病率上升以及對先進診斷和治療方案不斷增長的需求所推動的。

慢性阻塞性肺病是一種慢性進行性疾病，包括慢性支氣管炎和氣喘等疾病，是全世界主要的健康問題。根據世界衛生組織 (WHO) 的數據，2019 年有 323 萬人死於慢性阻塞性肺病，使其成為全球第三大死因。值得注意的是，70 歲以下人群中近 90% 的慢性阻塞性肺病相關死亡發生在低收入和中等收入國家。慢性阻塞性肺病盛行率的上升預計將增加對介入肺部手術的需求，從而推動市場成長。

隨著世界人口老化，患有呼吸道疾病和其他相關疾病的人數不斷增加。隨著預期壽命的增加，65歲以上人口的比例也增加，導致呼吸介入手術的需求增加。這些人口變化預計將有助於長期市場擴張。

本報告提供全球呼吸系統介入市場相關調查，提供市場概要，以及各產品，各適應症，各終端用戶，向各地區趨勢，及市場參與市場企業的競爭趨勢等資訊。

目錄

第1章 摘要整理

第2章 市場概要

  • 市場定義和市場區隔
  • 市場動態
  • 價值鏈分析
  • 波特的五力分析
  • COVID-19影響分析
  • 烏克蘭·俄羅斯糾紛的影響
  • 經濟概要
  • 大環境分析

第3章 價格分析，2019年～2023年

第4章 全球呼吸系統介入市場預測，2019年～2031年

  • 全球呼吸系統介入市場預測，各產品，金額(10億美元)，數量(台)，2019年～2031年
  • 全球呼吸系統介入市場預測，各適應症，金額(10億美元)，數量(台)，2019年～2031年
  • 全球呼吸系統介入市場預測，各終端用戶，金額(10億美元)，數量(台)，2019年～2031年
  • 全球呼吸系統介入市場預測，各地區，金額(10億美元)，數量(台)，2019年～2031年

第5章 北美的呼吸系統介入市場預測，2019年～2031年

第6章 歐洲的呼吸系統介入市場預測，2019年～2031年

第7章 亞太地區的呼吸系統介入市場預測，2019年～2031年

第8章 南美的呼吸系統介入市場預測，2019年～2031年

第9章 中東·非洲的呼吸系統介入市場預測，2019年～2031年

第10章 競爭情形

  • 產品和適應症的熱圖
  • 企業市場佔有率分析，2023年
  • 競爭儀表板
  • 企業簡介
    • Medtronic Plc
    • Boston Scientific Corporation
    • Olympus Corporation
    • FUJIFILM Corporation
    • Becton, Dickinson and Company
    • Smith's Group Plc
    • Cook Medical
    • Vygon
    • Clarus Medical LLC
    • Huger Medical Instrument Co. Ltd
    • Taewoong Medical Co. Ltd.
    • Shanghai AoHua Photoelectricity Endoscope Co., Ltd

第11章 附錄

簡介目錄

The global interventional pulmonology market, projected to achieve revenues of US$ 1.3 billion by 2024, is poised for significant growth. With a compound annual growth rate (CAGR) of 5%, the market is expected to reach a valuation of US$ 1.85 billion by 2031. This robust growth is fueled by the increasing prevalence of chronic obstructive pulmonary disease (COPD) and the escalating demand for advanced diagnostic and treatment options.

Increasing COPD Incidence Driving Market Growth

COPD, a chronic and progressive condition encompassing disorders such as chronic bronchitis and asthma, is a major health concern globally. According to the World Health Organization (WHO), 3.23 million individuals died from COPD in 2019, making it the third most common cause of death worldwide. Notably, nearly 90% of COPD-related deaths in people under the age of 70 occur in low- and middle-income nations. The rising incidence of COPD is expected to increase the demand for interventional pulmonary procedures, thereby driving market growth.

Impact of Smoking on COPD Rates

The American Lung Association highlights that the majority of COPD cases are caused by smoking cigarettes. Current smokers are seven times more likely to develop COPD, while former smokers are five times more likely compared to non-smokers. The widespread use of tobacco and nicotine-based smoking products contributes significantly to lung health issues. This escalating demand for diagnosis and treatment options for lung illnesses is expected to boost the interventional pulmonology market.

Aging Population and Respiratory Disorders

The global population is aging, and the number of individuals with respiratory disorders and other associated conditions is rising. As life expectancy increases, the proportion of individuals over 65 also grows, leading to higher demand for interventional pulmonary procedures. This demographic shift is expected to contribute to market expansion over time.

Factors Driving Market Growth Over the Forecast Period

Increasing Healthcare Spending and Improving Healthcare Infrastructure

Enhanced healthcare infrastructure and increased healthcare expenditures by public bodies are supporting the adoption and use of advanced medical devices in healthcare facilities. This trend is expected to drive the demand for interventional pulmonology procedures. Emerging economies such as India, Brazil, and Mexico, which have high COPD patient populations, present significant opportunities for market growth. Economic development and rising disposable income in these regions are expected to secure the market's long-term viability.

Advancement in Technology

Technological advancements in interventional pulmonology devices are expected to enhance the outcomes of pulmonary procedures. Manufacturers are incorporating advanced unreactive materials, such as silicon coatings, to prevent microbial film formation on bronchoscopes. Additionally, extra-thin manufacturing processes and higher-resolution cameras are being used to improve bronchoscopy techniques. These innovations are expected to uplift the market.

Manufacturers are also developing insertion tubes that can be easily rotated to reduce practitioner stress and fatigue. The miniaturization of endoscopic equipment and the introduction of ultra-slim designs for observing thin bronchi are among the strategies being employed to improve device performance.

Rising Demand for Improved Bronchoscopy Techniques

Technological advancements in bronchoscopy are contributing to the growth of the global interventional pulmonology market. Improvements in electronics and microtechnology have led to safer and more accurate diagnoses of lung disorders, resulting in better patient outcomes. The demand for advanced bronchoscopy techniques is expected to drive market growth throughout the forecast period.

Challenges Facing the Interventional Pulmonology Market

Lack of Awareness Regarding Symptoms of Asthma and COPD

A significant challenge facing the market is the lack of awareness about the symptoms of asthma and COPD. Many individuals with respiratory illnesses remain undiagnosed and untreated, particularly in low-income countries. This lack of awareness is a major impediment to market growth.

Availability of Non-Invasive Options and Strict Regulations

The development of non-invasive diagnostic techniques, such as liquid biopsies and magnetic resonance spectroscopy, poses a challenge to the growth of the interventional pulmonology market. Additionally, stringent regulatory requirements, such as pre-market approval (PMA) for Class III devices by the FDA, add to the market's challenges. The rigorous approval processes and the need for clinical evidence for high-risk devices are hindering market expansion.

Associated Side Effects of Bronchoscopy Procedures

Bronchoscopy procedures carry risks such as contamination, infection, bleeding, breathing difficulties, and low blood oxygen levels. These complications reduce the adoption rates of bronchoscopy techniques. The advent of methicillin-resistant Staphylococcus aureus and other resistant bacteria has increased the likelihood of post-bronchoscopy infections, further limiting market growth.

Country-Wise Insights

Why is the U.S. Market Booming?

Increasing Prevalence of Asthma

In 2022, the U.S. accounted for approximately 90.7% of the North American interventional pulmonology market. According to the Asthma and Allergy Foundation of America, around 25 million people in the U.S. suffer from asthma, which corresponds to about 1 in every 13 individuals. This high prevalence of asthma is driving the demand for interventional pulmonology procedures.

Will Germany Be a Lucrative Market for Interventional Pulmonology Manufacturers?

Rising Cases of COPD

Germany holds an 18.3% market share in Europe. An estimated 10-12% of German adults over the age of 40 have COPD. By 2030, the number of COPD patients in Germany is expected to rise to 7.9 million from 6.8 million in 2010. Smoking and occupational air pollution are significant contributors to respiratory illnesses in the country, making COPD one of the most prevalent disorders.

How is China Emerging as a Prominent Market for Interventional Pulmonology?

Growing Geriatric Population

In 2022, China held a market share of about 52.8% of the East Asian interventional pulmonology market. WHO estimates indicate that China has one of the world's fastest-growing aging populations. By 2040, 28% of China's population is expected to be over 60. This large geriatric population, coupled with rising respiratory ailments, presents lucrative growth opportunities for the interventional pulmonology market.

Key Industry Players:

  • Medtronic Plc
  • Boston Scientific Corporation
  • Olympus Corporation
  • FUJIFILM Corporation
  • Becton, Dickinson and Company
  • Smith's Group Plc
  • Cook Medical
  • Vygon
  • Clarus Medical LLC
  • Huger Medical Instrument Co. Ltd
  • Taewoong Medical Co. Ltd.
  • Shanghai AoHua Photoelectricity Endoscope Co., Ltd
  • Karl Storz
  • Richard Wolf Corporation
  • PENTAX Medical

Market Segmentation

By Product:

  • Bronchoscopes
    • Fiberoptic (flexible) Bronchoscope
    • Rigid bronchoscope
    • Endobronchial Ultrasound Bronchoscope (EBUS)
  • Convex EBUS
  • Radial EBUS
  • Respiratory Endotherapy Devices
    • Aspiration Needles
    • Biopsy Forceps
    • Other
  • ENB Systems
  • Pleuroscopes
    • Semi flexible Pleuroscopes
    • Rigid Pleuroscopes
  • Airway Stents
  • Bronchial Thermoplasty Systems
  • Pleural Catheters
  • Endobronchial Valves

By Indication:

  • Lung Cancer
  • Asthma
  • COPD
  • Foreign Body Extraction
  • Tracheal and Bronchial Stenosis
  • Others

By End User:

  • Hospitals
  • Pulmonology Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Centers

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

"

Table of Contents

1. Executive Summary

  • 1.1. Global Interventional Pulmonology Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Price Analysis, 2019 - 2023

  • 3.1. Global Average Price Analysis, by Product, US$ Per Unit, 2019 - 2023
  • 3.2. Prominent Factor Affecting Interventional Pulmonology Products Prices
  • 3.3. Global Average Price Analysis, by Region, US$ Per Unit

4. Global Interventional Pulmonology Market Outlook, 2019 - 2031

  • 4.1. Global Interventional Pulmonology Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Bronchoscopes
        • 4.1.1.1.1. Fiberoptic (flexible) Bronchoscope
        • 4.1.1.1.2. Rigid bronchoscope
        • 4.1.1.1.3. Endobronchial Ultrasound Bronchoscope (EBUS)
          • 4.1.1.1.3.1. Convex EBUS
          • 4.1.1.1.3.2. Radial EBUS
      • 4.1.1.2. Respiratory Endotherapy Devices
        • 4.1.1.2.1. Aspiration Needles
        • 4.1.1.2.2. Biopsy Forceps
        • 4.1.1.2.3. Other
      • 4.1.1.3. ENB Systems
      • 4.1.1.4. Pleuroscopes
        • 4.1.1.4.1. Semi flexible Pleuroscopes
        • 4.1.1.4.2. Rigid Pleuroscopes
      • 4.1.1.5. Airway Stents
      • 4.1.1.6. Bronchial Thermoplasty Systems
      • 4.1.1.7. Pleural Catheters
      • 4.1.1.8. Endobronchial Valves
  • 4.2. Global Interventional Pulmonology Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Lung Cancer
      • 4.2.1.2. Asthma
      • 4.2.1.3. COPD
      • 4.2.1.4. Foreign Body Extraction
      • 4.2.1.5. Tracheal and Bronchial Stenosis
      • 4.2.1.6. Others
  • 4.3. Global Interventional Pulmonology Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Hospitals
      • 4.3.1.2. Pulmonology Clinics
      • 4.3.1.3. Ambulatory Surgical Centers
      • 4.3.1.4. Diagnostic Centers
  • 4.4. Global Interventional Pulmonology Market Outlook, by Region, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. North America
      • 4.4.1.2. Europe
      • 4.4.1.3. Asia Pacific
      • 4.4.1.4. Latin America
      • 4.4.1.5. Middle East & Africa

5. North America Interventional Pulmonology Market Outlook, 2019 - 2031

  • 5.1. North America Interventional Pulmonology Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Bronchoscopes
        • 5.1.1.1.1. Fiberoptic (flexible) Bronchoscope
        • 5.1.1.1.2. Rigid bronchoscope
        • 5.1.1.1.3. Endobronchial Ultrasound Bronchoscope (EBUS)
          • 5.1.1.1.3.1. Convex EBUS
          • 5.1.1.1.3.2. Radial EBUS
      • 5.1.1.2. Respiratory Endotherapy Devices
        • 5.1.1.2.1. Aspiration Needles
        • 5.1.1.2.2. Biopsy Forceps
        • 5.1.1.2.3. Other
      • 5.1.1.3. ENB Systems
      • 5.1.1.4. Pleuroscopes
        • 5.1.1.4.1. Semi flexible Pleuroscopes
        • 5.1.1.4.2. Rigid Pleuroscopes
      • 5.1.1.5. Airway Stents
      • 5.1.1.6. Bronchial Thermoplasty Systems
      • 5.1.1.7. Pleural Catheters
      • 5.1.1.8. Endobronchial Valves
  • 5.2. North America Interventional Pulmonology Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Lung Cancer
      • 5.2.1.2. Asthma
      • 5.2.1.3. COPD
      • 5.2.1.4. Foreign Body Extraction
      • 5.2.1.5. Tracheal and Bronchial Stenosis
      • 5.2.1.6. Others
  • 5.3. North America Interventional Pulmonology Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Hospitals
      • 5.3.1.2. Pulmonology Clinics
      • 5.3.1.3. Ambulatory Surgical Centers
      • 5.3.1.4. Diagnostic Centers
  • 5.4. North America Interventional Pulmonology Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. U.S. Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 5.4.1.2. U.S. Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 5.4.1.3. U.S. Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 5.4.1.4. Canada Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 5.4.1.5. Canada Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 5.4.1.6. Canada Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Europe Interventional Pulmonology Market Outlook, 2019 - 2031

  • 6.1. Europe Interventional Pulmonology Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Bronchoscopes
        • 6.1.1.1.1. Fiberoptic (flexible) Bronchoscope
        • 6.1.1.1.2. Rigid bronchoscope
        • 6.1.1.1.3. Endobronchial Ultrasound Bronchoscope (EBUS)
          • 6.1.1.1.3.1. Convex EBUS
          • 6.1.1.1.3.2. Radial EBUS
      • 6.1.1.2. Respiratory Endotherapy Devices
        • 6.1.1.2.1. Aspiration Needles
        • 6.1.1.2.2. Biopsy Forceps
        • 6.1.1.2.3. Other
      • 6.1.1.3. ENB Systems
      • 6.1.1.4. Pleuroscopes
        • 6.1.1.4.1. Semi flexible Pleuroscopes
        • 6.1.1.4.2. Rigid Pleuroscopes
      • 6.1.1.5. Airway Stents
      • 6.1.1.6. Bronchial Thermoplasty Systems
      • 6.1.1.7. Pleural Catheters
      • 6.1.1.8. Endobronchial Valves
  • 6.2. Europe Interventional Pulmonology Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Lung Cancer
      • 6.2.1.2. Asthma
      • 6.2.1.3. COPD
      • 6.2.1.4. Foreign Body Extraction
      • 6.2.1.5. Tracheal and Bronchial Stenosis
      • 6.2.1.6. Others
  • 6.3. Europe Interventional Pulmonology Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Hospitals
      • 6.3.1.2. Pulmonology Clinics
      • 6.3.1.3. Ambulatory Surgical Centers
      • 6.3.1.4. Diagnostic Centers
  • 6.4. Europe Interventional Pulmonology Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. Germany Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.2. Germany Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.3. Germany Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.4. U.K. Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.5. U.K. Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.6. U.K. Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.7. France Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.8. France Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.9. France Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.10. Italy Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.11. Italy Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.12. Italy Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.13. Turkey Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.14. Turkey Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.15. Turkey Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.16. Russia Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.17. Russia Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.18. Russia Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.19. Rest of Europe Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.20. Rest of Europe Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 6.4.1.21. Rest of Europe Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Asia Pacific Interventional Pulmonology Market Outlook, 2019 - 2031

  • 7.1. Asia Pacific Interventional Pulmonology Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Bronchoscopes
        • 7.1.1.1.1. Fiberoptic (flexible) Bronchoscope
        • 7.1.1.1.2. Rigid bronchoscope
        • 7.1.1.1.3. Endobronchial Ultrasound Bronchoscope (EBUS)
          • 7.1.1.1.3.1. Convex EBUS
          • 7.1.1.1.3.2. Radial EBUS
      • 7.1.1.2. Respiratory Endotherapy Devices
        • 7.1.1.2.1. Aspiration Needles
        • 7.1.1.2.2. Biopsy Forceps
        • 7.1.1.2.3. Other
      • 7.1.1.3. ENB Systems
      • 7.1.1.4. Pleuroscopes
        • 7.1.1.4.1. Semi flexible Pleuroscopes
        • 7.1.1.4.2. Rigid Pleuroscopes
      • 7.1.1.5. Airway Stents
      • 7.1.1.6. Bronchial Thermoplasty Systems
      • 7.1.1.7. Pleural Catheters
      • 7.1.1.8. Endobronchial Valves
  • 7.2. Asia Pacific Interventional Pulmonology Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Lung Cancer
      • 7.2.1.2. Asthma
      • 7.2.1.3. COPD
      • 7.2.1.4. Foreign Body Extraction
      • 7.2.1.5. Tracheal and Bronchial Stenosis
      • 7.2.1.6. Others
  • 7.3. Asia Pacific Interventional Pulmonology Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Hospitals
      • 7.3.1.2. Pulmonology Clinics
      • 7.3.1.3. Ambulatory Surgical Centers
      • 7.3.1.4. Diagnostic Centers
  • 7.4. Asia Pacific Interventional Pulmonology Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. China Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.2. China Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.3. China Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.4. Japan Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.5. Japan Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.6. Japan Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.7. South Korea Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.8. South Korea Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.9. South Korea Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.10. India Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.11. India Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.12. India Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.13. Southeast Asia Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.14. Southeast Asia Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.15. Southeast Asia Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.16. Rest of Asia Pacific Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.17. Rest of Asia Pacific Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 7.4.1.18. Rest of Asia Pacific Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Latin America Interventional Pulmonology Market Outlook, 2019 - 2031

  • 8.1. Latin America Interventional Pulmonology Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Bronchoscopes
        • 8.1.1.1.1. Fiberoptic (flexible) Bronchoscope
        • 8.1.1.1.2. Rigid bronchoscope
        • 8.1.1.1.3. Endobronchial Ultrasound Bronchoscope (EBUS)
          • 8.1.1.1.3.1. Convex EBUS
          • 8.1.1.1.3.2. Radial EBUS
      • 8.1.1.2. Respiratory Endotherapy Devices
        • 8.1.1.2.1. Aspiration Needles
        • 8.1.1.2.2. Biopsy Forceps
        • 8.1.1.2.3. Other
      • 8.1.1.3. ENB Systems
      • 8.1.1.4. Pleuroscopes
        • 8.1.1.4.1. Semi flexible Pleuroscopes
        • 8.1.1.4.2. Rigid Pleuroscopes
      • 8.1.1.5. Airway Stents
      • 8.1.1.6. Bronchial Thermoplasty Systems
      • 8.1.1.7. Pleural Catheters
      • 8.1.1.8. Endobronchial Valves
  • 8.2. Latin America Interventional Pulmonology Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Lung Cancer
      • 8.2.1.2. Asthma
      • 8.2.1.3. COPD
      • 8.2.1.4. Foreign Body Extraction
      • 8.2.1.5. Tracheal and Bronchial Stenosis
      • 8.2.1.6. Others
  • 8.3. Latin America Interventional Pulmonology Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Hospitals
      • 8.3.1.2. Pulmonology Clinics
      • 8.3.1.3. Ambulatory Surgical Centers
      • 8.3.1.4. Diagnostic Centers
  • 8.4. Latin America Interventional Pulmonology Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. Brazil Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 8.4.1.2. Brazil Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 8.4.1.3. Brazil Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 8.4.1.4. Mexico Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 8.4.1.5. Mexico Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 8.4.1.6. Mexico Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 8.4.1.7. Argentina Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 8.4.1.8. Argentina Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 8.4.1.9. Argentina Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 8.4.1.10. Rest of Latin America Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 8.4.1.11. Rest of Latin America Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 8.4.1.12. Rest of Latin America Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Middle East & Africa Interventional Pulmonology Market Outlook, 2019 - 2031

  • 9.1. Middle East & Africa Interventional Pulmonology Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 9.1.1. Key Highlights
      • 9.1.1.1. Bronchoscopes
        • 9.1.1.1.1. Fiberoptic (flexible) Bronchoscope
        • 9.1.1.1.2. Rigid bronchoscope
        • 9.1.1.1.3. Endobronchial Ultrasound Bronchoscope (EBUS)
          • 9.1.1.1.3.1. Convex EBUS
          • 9.1.1.1.3.2. Radial EBUS
      • 9.1.1.2. Respiratory Endotherapy Devices
        • 9.1.1.2.1. Aspiration Needles
        • 9.1.1.2.2. Biopsy Forceps
        • 9.1.1.2.3. Other
      • 9.1.1.3. ENB Systems
      • 9.1.1.4. Pleuroscopes
        • 9.1.1.4.1. Semi flexible Pleuroscopes
        • 9.1.1.4.2. Rigid Pleuroscopes
      • 9.1.1.5. Airway Stents
      • 9.1.1.6. Bronchial Thermoplasty Systems
      • 9.1.1.7. Pleural Catheters
      • 9.1.1.8. Endobronchial Valves
  • 9.2. Middle East & Africa Interventional Pulmonology Market Outlook, by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 9.2.1. Key Highlights
      • 9.2.1.1. Lung Cancer
      • 9.2.1.2. Asthma
      • 9.2.1.3. COPD
      • 9.2.1.4. Foreign Body Extraction
      • 9.2.1.5. Tracheal and Bronchial Stenosis
      • 9.2.1.6. Others
  • 9.3. Middle East & Africa Interventional Pulmonology Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 9.3.1. Key Highlights
      • 9.3.1.1. Hospitals
      • 9.3.1.2. Pulmonology Clinics
      • 9.3.1.3. Ambulatory Surgical Centers
      • 9.3.1.4. Diagnostic Centers
  • 9.4. Middle East & Africa Interventional Pulmonology Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 9.4.1. Key Highlights
      • 9.4.1.1. GCC Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.2. GCC Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.3. GCC Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.4. South Africa Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.5. South Africa Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.6. South Africa Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.7. Egypt Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.8. Egypt Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.9. Egypt Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.10. Nigeria Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.11. Nigeria Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.12. Nigeria Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.13. Rest of Middle East & Africa Interventional Pulmonology Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.14. Rest of Middle East & Africa Interventional Pulmonology Market by Indication, Value (US$ Bn) and Volume (Units), 2019 - 2031
      • 9.4.1.15. Rest of Middle East & Africa Interventional Pulmonology Market by End User, Value (US$ Bn) and Volume (Units), 2019 - 2031
    • 9.4.2. BPS Analysis/Market Attractiveness Analysis

10. Competitive Landscape

  • 10.1. Product vs Indication Heatmap
  • 10.2. Company Market Share Analysis, 2023
  • 10.3. Competitive Dashboard
  • 10.4. Company Profiles
    • 10.4.1. Medtronic Plc
      • 10.4.1.1. Company Overview
      • 10.4.1.2. Product Portfolio
      • 10.4.1.3. Financial Overview
      • 10.4.1.4. Business Strategies and Development
    • 10.4.2. Boston Scientific Corporation
      • 10.4.2.1. Company Overview
      • 10.4.2.2. Product Portfolio
      • 10.4.2.3. Financial Overview
      • 10.4.2.4. Business Strategies and Development
    • 10.4.3. Olympus Corporation
      • 10.4.3.1. Company Overview
      • 10.4.3.2. Product Portfolio
      • 10.4.3.3. Financial Overview
      • 10.4.3.4. Business Strategies and Development
    • 10.4.4. FUJIFILM Corporation
      • 10.4.4.1. Company Overview
      • 10.4.4.2. Product Portfolio
      • 10.4.4.3. Financial Overview
      • 10.4.4.4. Business Strategies and Development
    • 10.4.5. Becton, Dickinson and Company
      • 10.4.5.1. Company Overview
      • 10.4.5.2. Product Portfolio
      • 10.4.5.3. Financial Overview
      • 10.4.5.4. Business Strategies and Development
    • 10.4.6. Smith's Group Plc
      • 10.4.6.1. Company Overview
      • 10.4.6.2. Product Portfolio
      • 10.4.6.3. Financial Overview
      • 10.4.6.4. Business Strategies and Development
    • 10.4.7. Cook Medical
      • 10.4.7.1. Company Overview
      • 10.4.7.2. Product Portfolio
      • 10.4.7.3. Financial Overview
      • 10.4.7.4. Business Strategies and Development
    • 10.4.8. Vygon
      • 10.4.8.1. Company Overview
      • 10.4.8.2. Product Portfolio
      • 10.4.8.3. Financial Overview
      • 10.4.8.4. Business Strategies and Development
    • 10.4.9. Clarus Medical LLC
      • 10.4.9.1. Company Overview
      • 10.4.9.2. Product Portfolio
      • 10.4.9.3. Financial Overview
      • 10.4.9.4. Business Strategies and Development
    • 10.4.10. Huger Medical Instrument Co. Ltd
      • 10.4.10.1. Company Overview
      • 10.4.10.2. Product Portfolio
      • 10.4.10.3. Financial Overview
      • 10.4.10.4. Business Strategies and Development
    • 10.4.11. Taewoong Medical Co. Ltd.
      • 10.4.11.1. Company Overview
      • 10.4.11.2. Product Portfolio
      • 10.4.11.3. Financial Overview
      • 10.4.11.4. Business Strategies and Development
    • 10.4.12. Shanghai AoHua Photoelectricity Endoscope Co., Ltd
      • 10.4.12.1. Company Overview
      • 10.4.12.2. Product Portfolio
      • 10.4.12.3. Financial Overview
      • 10.4.12.4. Business Strategies and Development

11. Appendix

  • 11.1. Research Methodology
  • 11.2. Report Assumptions
  • 11.3. Acronyms and Abbreviations